Hybrid AI for Pharma and Life Sciences

Your Scientists Already Use AI. Your Compounds Shouldn’t Be the Price. With Axenivo, They Never Are.

Hybrid AI that routes every request. Private models in your own cloud for trial, safety and compound data. Leading managed models like Claude or GPT for published literature and public guidance. Answers that reason like your scientists and regulatory writers, at a cost you can forecast.

How Axenivo routes every request Animated diagram. Requests from scientists and workflows, such as trial data, safety cases, compound questions and published literature, fall into a funnel and pass a policy check. Anything involving confidential or regulated data, or where the check is unsure, goes to private AI in your own cloud, which draws on your own knowledge base of SOPs, templates and prior dossiers. Public-only work can go to managed AI such as Claude, GPT or Grok. Both routes return one answer, cited to your SOP, at optimized cost. A SCIENTIST OR WORKFLOW ASKS Trial dataSafety caseCompoundLiterature Policy Check Confidential Data? Yes, or Unsure Public Only YOUR CLOUD Private AI Your data never leaves Your SLM Open LLM Chem model Your knowledge baseRAG WHERE IT HELPS Managed AI Public sources only Claude · GPT · Grok Zero private data One Answer Cited to your SOP. Optimized cost. How Axenivo routes every request Animated diagram. Requests from scientists and workflows, such as trial data, safety cases, compound questions and published literature, fall into a funnel and pass a policy check. Anything involving confidential or regulated data, or where the check is unsure, goes to private AI in your own cloud, which draws on your own knowledge base of SOPs, templates and prior dossiers. Public-only work can go to managed AI such as Claude, GPT or Grok. Both routes return one answer, cited to your SOP, at optimized cost. A SCIENTIST OR WORKFLOW ASKS Trial dataSafety caseCompoundLiterature Policy Check Confidential Data? Yes, or Unsure Public Only YOUR CLOUD Private AI Your data never leaves Your SLM Open LLM Chem model Your knowledge base WHERE IT HELPS Managed AI Public sources only Claude, GPT or Grok Zero private data One Answer Cited to your SOP. Optimized cost.
  • Your Data Stays in Your CloudTrial data, safety cases and compound libraries never reach a public AI vendor.
  • Hybrid by DesignA policy check sends each task to the right model: private for confidential data, managed where it helps.
  • A Cost You Can ForecastNo per-token fees on confidential work, however many cases and documents you process.

Built for

  • Pharma Companies
  • Biotechs
  • Biologics and Vaccine Makers
  • Generics Manufacturers
  • Research Institutes
  • CROs and CDMOs

AI Is Already in Your Labs. But Control Isn’t.

Pharma AI rarely fails for lack of good models. Control breaks down for five reasons, and most pharma, biotech and research organisations recognise at least one of them.

Reason 1Shadow AI

Your scientists are already using AI. Just not yours.

Compound structures, trial results and draft submissions get pasted into public chatbots because the approved tool is too weak or too slow.

The cost: An IP and data-protection risk you can’t see or audit.

Reason 2Stalled Pilots

Your AI pilot never reached real data.

Legal, QA and data-protection reviews won’t approve sending trial data or unpublished research to an outside AI vendor, so AI stays on public literature.

The cost: You pay for AI that never touches the work that matters.

Reason 3Generic Output

Every answer sounds like every other company’s.

General-purpose models ignore your SOPs, templates and prior dossiers, so scientists and writers rewrite what comes back.

The cost: The time AI was meant to save disappears in the rewrite.

Reason 4Runaway Cost

The AI bill grows with every study.

Safety cases, documents and literature feeds grow with every study and product. Per-token pricing turns every case narrative and every screened paper into a line item finance can’t forecast.

The cost: The more work you automate, the less you can afford to.

Reason 5Inspection Scrutiny

Inspectors and auditors are asking questions you can’t answer yet.

QA, auditors and health authority inspectors now ask how AI contributed to a document, which data it saw and who approved it.

The cost: Untraceable AI puts submissions, inspections and timelines at risk.

It doesn’t have to be a trade-off.

Axenivo keeps confidential data private, uses Claude or GPT only where it helps, reasons like your scientists, and turns runaway token spend into a cost you can plan.

See how hybrid routing works

CRO or CDMO? The same five problems show up with a twist: every sponsor’s data must stay separate, and sponsors audit how you use AI. See the CRO and CDMO page.

Hybrid AI: Private Where It Matters, Managed Where It Helps

Hybrid AI is the core of Axenivo. Every request passes a policy check before any model sees it. Trial, safety, compound and submission data runs on LLMs on GPUs in your own cloud, with no per-token fees. Work with no confidential data, such as summarising published literature or tracking public guidance, can use Claude or GPT, billed per token for that share only. When in doubt, it stays private.

Battery of LLMs GPU Claude / GPT API

A RequestFrom a scientist or workflow

Policy CheckConfidential data?

Private Where It MattersLLMs on GPUs in your own cloud

Managed Where It HelpsPer token, public work only

One AnswerLower cost per answer

Sovereign Where It Matters

Trial data, safety cases, compound libraries and unpublished research are handled only by open-source models you control. When in doubt, a request stays private.

Frontier Capability Where It Helps

Managed models such as Claude, GPT or Grok read published literature, public guidance and competitor news without ever seeing your data. You pay per token only for this share of the work.

The Right-Sized Model for Each Task

Routine work such as case intake and document checks is handled by small, fast models. Large models are reserved for complex drafting and analysis.

What goes where: the policy check routes each task, and you can tighten any line
TaskRouteWhat the model sees
Clinical study reports and trial summariesPrivate AIPatient-level trial data, listings and investigator notes
Safety case intake and narrativesPrivate AIAdverse event reports, patient details and medical history
Regulatory submission draftingPrivate AIUnpublished results, your prior dossiers and agency correspondence
Compound and assay data analysisPrivate AIStructures, assay results and your structure-activity data
Lab notebook structuringPrivate AIExperimental records, methods and raw observations
Patent and freedom-to-operate scansPrivate AIYour invention disclosures, compared with public patents inside your cloud
Published literature summariesManaged AIJournal articles, preprints and public trial registries
Public guidance trackingManaged AIPublic texts from ICH, EMA, FDA and other health authorities
Competitive landscape trackingManaged AIPublic pipelines, press releases and conference abstracts, never your plans

Use Cases and Pharma Scenarios

See how Axenivo answers: a scientist asks, and every answer separates observation from interpretation, states its confidence, cites your own SOP and shows which side of the hybrid route handled it.

Input

Spontaneous adverse event report from your safety inbox

Private AIConfidential data: stays in your cloud

Case AE-26-0418 Synthetic example
FieldReported
Suspect drugAXV-201, 20 mg
EventLiver enzymes raised
OnsetDay 34 of treatment
OutcomeRecovering after stop
Safety scientist

Process this case against our case-processing SOP.

Axenivo Draft for expert review
Observation
ALT 5.2× the upper limit of normal on day 34, with normal bilirubin; the drug was stopped and values are falling.
Interpretation
Possible drug-induced liver injury. The event is not listed in your reference safety information; no seriousness criteria are met on current information.
Confidence
Moderate. Concomitant medications are only partly reported.
Grounded in your SOP
Case-processing SOP PV-012, seriousness and expectedness assessment (section 5.3), and the current reference safety information.
Safety scientist action
Safety scientist confirms the coding and assessment, requests follow-up information and decides the reporting timeline.

Illustrative examples with synthetic data. These are not real patients, compounds, studies or model output; they show the format of Axenivo’s answers. Document names and sections are examples of your own SOPs.

Scenarios by team and task

Drug safety “Is this case serious, and is it expected?” Grounded in: Your case-processing SOPs and reference safety information. Private AIPilot-ready Clinical operations “Summarise the protocol deviations from this site.” Grounded in: Your monitoring plan and deviation SOP. Private AIPilot-ready Medical writing “Draft the CSR results section in our template.” Grounded in: Your templates, style guide and source tables. Private AIPilot-ready Regulatory affairs “Draft a response to this agency question.” Grounded in: Your prior dossiers, responses and regulatory SOPs. Private AIPilot-ready Discovery “Which compounds in this series fit our target profile?” Grounded in: Your assay data and lead-selection criteria. Private AIPilot-ready IP and patents “Does this disclosure overlap with published patents?” Grounded in: Your disclosures, compared with public patent data in your cloud. Private AIValidation first Quality and GMP “Which SOPs does this deviation touch?” Grounded in: Your quality system, SOPs and batch records. Private AIPilot-ready Literature “What’s new on this target this month?” Grounded in: Published literature and public trial registries. Managed AIPilot-ready Competitive intelligence “Summarise competitor pipeline news this quarter.” Grounded in: Public pipelines, press releases and conference abstracts. Managed AIPilot-ready Every team “What does our SOP say for this situation?” Grounded in: Your SOPs, work instructions and templates. Private AIPilot-ready
See every use case and scenario in detail

Every Lab Will Have AI. Only Yours Will Know Your Compounds.

General-purpose assistants give every company the same answers. As more research and regulatory work passes through AI, the know-how that sets your organisation apart becomes available to anyone with a subscription.

AspectGeneric AIAxenivo
Learns fromPublic data, the same for every customerYour SOPs, assay data, study reports and prior dossiers
Reasons likeThe vendor’s house styleYour scientists, safety physicians and regulatory writers
Judged byThe vendor’s benchmarksYour experts, on real cases and documents
ImprovesWhen the vendor updates everyoneEvery time your experts review a draft
UsesOne vendor’s model for everythingPrivate models for confidential data, managed models where they help
Runs onThe vendor’s serversYour own cloud account

Your Competitor Can License the Same Model Tomorrow. They Can’t License Your Compounds, Your Data or Your Scientists’ Judgement.

Scientists reviewing assay results together in a laboratory

Five Reasons Pharma and Biotech Companies Choose Axenivo

Exclusive

Your science, your AI.

Its knowledge, reasoning and quality standard come from your experts. Nothing you build trains anyone else’s model.

Private

Confidential by design.

Every model that sees trial, safety or compound data runs in your cloud account. We operate the platform without any access to your data.

Traceable

Ready for QA and inspection.

Experts rate answers on real cases, every answer cites its source, and every change is versioned and tested. A change goes live only when it meets your standard.

Hybrid

The strongest model for each task.

Private models for confidential data, Claude or GPT for published literature. Agentic RAG pulls in the exact SOP or prior dossier. New models are adopted only after testing on your cases.

Efficient

Costs less as volumes grow.

Small models first, capacity that follows working hours and batch runs, and no per-token fees on confidential work. Managed AI is paid for only where it earns its place.

What exactly leaves your account?

Everything Under the Hood, Built for Pharma R&D and Regulatory Work

A complete hybrid AI stack, operated for you. Each capability runs where it belongs: private for confidential data, managed where public sources help.

Battery of LLMs

Several large models on call, each chosen per task, so no single model or vendor limits your work.

Private + Managed

Small Language Models

Fast, efficient SLMs handle routine work first, such as case intake and document checks, keeping each answer quick and low-cost.

Private

Fine-Tuned Models

Models tuned on your templates, SOPs and approved documents, so drafts read like your team wrote them.

Private

Agentic Document Assembly

Supervised agents gather source tables, prior dossiers and SOPs into one working draft, with an expert approving each outcome.

Private + Managed

Scientific Data Analysis

Analysis over your own assay, stability and study data surfaces trends and outliers, next to the tools your scientists already use.

Private

Literature and Guidance Research

Published papers, trial registries and public guidance from ICH, EMA and FDA, read from public sources and kept current.

Managed

Structured Citations

Every answer cites its source to the SOP, table or paper, with observation kept separate from interpretation.

Private + Managed

Purpose-Built Document Parsing

Study reports, batch records, lab notebooks, scanned case forms and patents read accurately, with low-quality pages flagged for review.

Private

Validation Support

Evidence for computerised system validation: versioned configurations, test records and change history, written to your QA standard.

Private

Policy Check, Audit Trails and Role-Based Approvals

Governance built in from day one, the way regulated GxP work already runs.

Private
  • Confidential-Data Policy CheckEvery request is checked before any model sees it. Anything involving trial, safety, compound or submission data, or where the check is unsure, stays private.
  • Audit TrailsEvery request, source, route and approval is logged in your account, ready for QA, auditors, inspectors and sponsors.
  • Role-Based Access and ApprovalsScientists, writers, safety teams and business users see only what their role allows, with second approval where your SOP requires it.

Private runs in your cloudManaged public sources onlyPrivate + Managed routed per request

  • Your Knowledge
  • Hybrid AI
  • Your Experts Approve

Hybrid AI That Costs Less as You Grow

Every AI workload has a break-even point. Below it, paying per token is cheaper; above it, owned capacity wins. Pharma work scales with every study, safety case and literature feed, so much of it crosses that line early. Axenivo puts each workload on the right side of the line, and moves it when it crosses.

Pay-per-use AI: cost rises with every request Private AI you build and staff yourself Axenivo hybrid: engineered to stay lean

Illustrative. Monthly cost (vertical) against monthly usage (horizontal); dots mark each break-even point.

Where the Savings Come From

  • Small Models FirstMost requests never reach the most expensive models.
  • Capacity That Follows Your Day and Batch RunsComputing scales with working hours, overnight literature runs and submission peaks, so you do not pay for idle hardware.
  • Shared HardwareSeveral models and tasks share the same processors instead of each needing their own.
  • No Platform Team on Your PayrollWe run the engineering that would otherwise need a dedicated team.
  • Managed AI Only Where It PaysPer-token spend is limited to the tasks that need it, under a monthly cap. Confidential work carries no per-token fee.

At very low volumes, pay-per-use can be cheaper. Our break-even calculator shows where your organisation sits. Cost is one reason for hybrid AI, not the only one: trade secrets and patient confidentiality often justify private AI before the numbers do.

Pharma AI Without the Build Project

Building hybrid AI for R&D and regulatory work yourself means hiring a team, building a platform and passing IT, QA and data-protection reviews before a single scientist benefits. With Axenivo, you skip straight to the part that matters: your scientists using it.

Hours, Not Months

Your private environment is running in hours, while a build-it-yourself project typically spends its first months on hiring and infrastructure. A supervised pilot with your experts follows within weeks.

No Hiring Race

No AI engineers, MLOps specialists or GPU experts to recruit in one of the tightest talent markets. Your IT team stays focused on the systems it already runs.

No New on-Call Rota

Upgrades, monitoring, scaling, security patches and model releases are handled around the clock. No infrastructure for your team to babysit.

Build it yourself
Hire the teamBuild the platformIntegrate modelsBuild evaluationSecurity reviewPilot
With Axenivo
Set upKnowledgePilotLive

Illustrative comparison of typical phases. Your timeline depends on scope and your own review processes.

Not a Prototype. Axenivo Runs on XePlatform.

XePlatform is our production AI operations platform, already running private and managed AI side by side inside customers’ own cloud accounts. Underneath is platform engineering on Kubernetes: a wide ecosystem of interconnected open-source tools for model serving, scaling, observability and security, integrated, tested and operated as one platform. Axenivo is the pharma and life sciences product built on it, so the engineering underneath is proven before your first pilot begins.

Kubernetes-Native Platform EngineeringIntegrated Open-Source EcosystemInfrastructure ProvisioningStaged Releases with RollbackObservability for AI and InfrastructureGPU Autoscaling and Backup

Where Your Teams Save Time First

Most teams start with one of these workflows. Every answer shows where it came from and which route handled it.

Safety Case Intake

Adverse event reports coded, checked and summarised against your case-processing SOP, so safety scientists start from a complete draft.

Regulatory Submission Drafts

CTD sections and agency responses drafted from your source data and prior dossiers, ready for the regulatory writer to verify.

Literature-to-Protocol Matching

New published evidence compared with your protocols, so study teams see what affects their design before it becomes a question.

Lab Notebook Structuring

Free-text experimental records turned into structured, searchable entries, linked to methods, materials and results.

Axenivo supports scientific, safety and regulatory work. It does not make decisions: a qualified expert reviews every output, and nothing is submitted or reported automatically.

Explore workflows, example outputs and team scenarios

How Axenivo Fits into Your Organisation

Your teams work with Axenivo inside your own cloud account. We run the platform from outside, with no access to what is inside.

PatientData Protected, Therapies Sooner
ScientistAsks, Reviews, Decides
Your own cloud account
Axenivo assistantReads study reports, safety cases and lab records, and answers with sources
Private AI modelsSmall models first, larger models when needed
Your Knowledge Base RAGSOPs, templates, prior dossiers and study reports, searched for every answer and cited to the section
Your quality standardExpert ratings that decide what goes live
Deployment, monitoring and updates, with no access to your data
Managed AI, where it helpsClaude, GPT or Grok, billed per token, never given confidential data

What Exactly Leaves Your Account?

Trial, safety and compound data: never, including prompts, outputs, documents and logs. Operational health metrics: only these, which you can inspect or switch off. Managed AI: only the public sources and public-only tasks you route to it, under a monthly cap you set. See the full data-flow breakdown.

From Introduction to a Supervised Pilot

Start with one workflow, often one safety or writing team. Your QA, IT and data-protection teams review in parallel, with documentation we supply.

  1. Set Up

    Hours

    Axenivo is installed in your cloud account or data centre, in the region you choose, in Europe or North America.

  2. Add Your Knowledge

    Days

    SOPs, templates, prior dossiers and reference documents are indexed, each source traceable. You choose which tasks may use managed AI.

  3. Pilot with Your Experts

    About four weeks

    Scientists and writers use Axenivo on real cases and documents, in parallel with today’s process, and rate every answer.

  4. Go Live

    When your standard is met

    The configuration your experts and QA approved goes live. Rolling back takes one step.

Trust You Can Verify, Not Just Read About

Pharma and biotech companies rightly ask for proof. Here is what you can inspect before you decide, and what your pilot hands you at the end.

Inspect Before You Decide

  • The ArchitectureLayers, boundaries and data flows, including exactly which tasks may reach managed AI, documented on our platform and security pages.
  • The Security OverviewControls, telemetry and access model, written for your CISO, DPO, QA team and sponsor audits.
  • The Evaluation MethodHow experts rate answers, and the thresholds that decide what goes live.
  • The Ownership TermsWhat you own and keep, including exit and continuity terms, set out in the contract.

What Your Pilot Produces

  • A Private ScorecardHow each model performed on your cases: accuracy, missed findings, citation errors and more.
  • An Outcome ReportCycle times and acceptance rates, compared with your own baseline.
  • Governance EvidenceDocumentation to support your impact assessment, supplier qualification and computerised system validation.
  • A Costed PlanWhat production will cost at your real case and document volumes, based on measured usage rather than estimates.

We Operate It. You Own It.

  • No New Team to HireNo AI engineers, DevOps staff or GPU specialists.
  • Run for You Around the ClockWe deploy, monitor, update and support the platform.
  • Yours If You LeaveYour knowledge base, models, ratings and settings stay with you and keep running.

Pricing, Explained

The platform subscription
A fixed fee covering operation, monitoring, updates, the release process and support.
Your cloud costs
Computing and storage in your own account, billed to you directly by your cloud provider, with no markup.
Managed AI, where you use it
Per-token charges for tasks with no confidential data, kept in check with a monthly cap.
Your pilot
A fixed-scope pilot, priced up front. Ask us for details.

No per-token fees for confidential work, however many cases and documents you process. Estimate your break-even point with our calculator.

How You Will Know It Works

Before the pilot starts, we record how your team works today. Then we measure the difference.

Case Processing TimeFrom safety report received to case ready for review
Drafting TimeTime to a reviewable first draft of a CSR section or agency response
Literature ScreeningTime spent screening new publications for relevance
Answer QualityAccuracy and missed findings, rated by your experts
Expert AcceptanceDrafts accepted with no or minor edits

Frequently Asked Questions

About hybrid, private and managed AI for pharma and life sciences.

More answers for security, QA and data-protection teams
What is hybrid AI for pharma and life sciences?

Hybrid AI uses different models for different tasks. In Axenivo, anything involving trial data, safety cases, compound data or unpublished research stays on private, open-source models in your own cloud, with small models answering first and larger models when needed. Tasks with no confidential data, such as summarising published literature or tracking public guidance, can use managed models such as Claude, GPT or Grok.

Why not private AI for everything, or a managed tool for everything?

Private-only means your scientists miss out on the most capable models for public literature. Managed-only sends confidential data to a vendor and bills every case and document by the token. Hybrid gives each task the right model: confidentiality where it matters, frontier capability where it helps, and the lower cost for each workload.

Can confidential data ever reach a managed model?

No. Every request passes a policy check before any model sees it. Anything involving trial, patient, safety, compound or submission data, or where the check is unsure, stays private. You decide which task types may use managed AI at all, and you can switch it off entirely.

Does Axenivo replace our safety database, LIMS or document management system?

No. Axenivo works on top of the systems you already run. Your safety database, LIMS, electronic lab notebook and document management system stay the systems of record; Axenivo helps your teams read, summarise and draft, grounded in your own SOPs.

Does Axenivo make safety, quality or regulatory decisions automatically?

No. Axenivo is decision support with human oversight. A qualified expert reviews every output and makes the decision, and nothing is submitted to a health authority or reported automatically. Your organisation defines the intended use of each workflow.

What is private AI for pharma and biotech?

In Axenivo, private AI is the part that handles confidential data. The models run inside your own cloud account or data centre, under your control, instead of on a vendor’s servers. Axenivo delivers it as an operated platform, so companies get the benefits without building an AI team.

How is Axenivo different from building pharma AI ourselves?

Running AI on confidential data is far more than provisioning a server with a GPU. It needs infrastructure provisioning as code, model serving, retrieval over your own SOPs, staging environments, release engineering with evaluation gates and rollback, observability, autoscaling, backup and security policy, all kept running every day. Axenivo delivers that complete stack, built on XePlatform, inside your own cloud account and operated for you, so a supervised pilot can start within weeks without new hires.

How does Axenivo support GxP, GDPR, HIPAA and the EU AI Act?

Axenivo is designed to support GDPR, HIPAA and EU AI Act obligations, as well as GxP expectations such as EU GMP Annex 11 and FDA 21 CFR Part 11. Confidential data is processed only inside your own account, every request and approval is logged, and we provide documentation for your impact assessments, supplier qualification and computerised system validation. Compliance itself depends on how your organisation uses the platform.

Which AI models does Axenivo use?

Open-source general and domain models run inside your account for all confidential work, alongside your own scientific models. New models are adopted only after they pass evaluation on your own cases. Managed models such as Claude, GPT or Grok are used only for tasks with no confidential data.

Can Axenivo run on-premise or in a private cloud?

Yes. Axenivo runs on the major public clouds in the region you choose, in Europe or North America, or in your private cloud or data centre, built on open standards so you can move without rebuilding.

How much does hybrid AI for pharma cost?

A fixed platform subscription plus your own cloud costs, with no per-token fees for confidential work. Managed AI is billed per token only for the tasks you route to it, under a monthly cap. Small models first, capacity that follows your working hours and batch runs, and shared hardware keep the cost of each answer low, which matters when case and document volumes grow with every study.

How long does a pilot take?

The environment is set up in hours and your SOPs loaded within days. A supervised pilot with your experts typically runs about four weeks, while your QA, IT and data-protection teams complete their review in parallel.

Latest from the Blog

Read all posts

Discuss a Pharma AI Pilot

Explore a supervised pilot using your own documents, infrastructure and evaluation criteria. Tell us the workflow that costs your experts the most time.